SLU-PP-1072

CAS No. 2285432-57-5

SLU-PP-1072( —— )

Catalog No. M36943 CAS No. 2285432-57-5

SLU-PP-1072 is an ERRα and ERRγ inverse dual agonist that disrupts PCa cell metabolism and induces apoptosis through cell cycle dysregulation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 116 In Stock
10MG 187 In Stock
25MG 377 In Stock
50MG 548 In Stock
100MG 784 In Stock
200MG Get Quote In Stock
500MG 1609 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SLU-PP-1072
  • Note
    Research use only, not for human use.
  • Brief Description
    SLU-PP-1072 is an ERRα and ERRγ inverse dual agonist that disrupts PCa cell metabolism and induces apoptosis through cell cycle dysregulation.
  • Description
    SLU-PP-1072 is a dual ERRα/γ inverse agonist, used in Prostate cancer (PCa) research. SLU-PP-1072 disrupts PCa cell metabolism, and induces apoptosis via dysregulating cell cycle.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis | Estrogen/progestogen Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2285432-57-5
  • Formula Weight
    336.36
  • Molecular Formula
    C18H12N2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (371.63 mM; Ultrasonic )
  • SMILES
    C(NC=1C=C2C(=CC1)N=CS2)(=O)C=3OC(=CC3)C4=CC=C(O)C=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Schoepke E, et al. A Selective ERRα/γ Inverse Agonist, SLU-PP-1072, Inhibits the Warburg Effect and Induces Apoptosis in Prostate Cancer Cells. ACS Chem Biol. 2020 Sep 18;15(9):2338-2345.?
molnova catalog
related products
  • AGN 192870

    AGN 192870 is a potent retinoic acid receptor (RAR) antagonist.AGN 192870 can be used to study cell growth arrest, differentiation and apoptosis.

  • Gardenoside

    Gardenoside can inhibit the secretion of gastric juice and reduce the role of pancreatic amylase.

  • Pivanex

    Pivanex is an orally active HDAC inhibitor and an antimetastatic and antiangiogenic agent. Pivanex downregulates the Bcr-Abl protein and enhances apoptosis.